002262 恩华药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)14.36016.65217.20217.08817.643
总资产报酬率 ROA (%)12.62614.50515.01814.79215.275
投入资产回报率 ROIC (%)13.69015.92316.69616.59817.173

边际利润分析
销售毛利率 (%)76.02373.55872.82976.26077.200
营业利润率 (%)27.85323.45823.45223.34423.525
息税前利润/营业总收入 (%)27.26122.45822.79822.54623.003
净利润/营业总收入 (%)24.70420.02220.51520.47420.277

收益指标分析
经营活动净收益/利润总额(%)97.92899.77496.64994.92898.285
价值变动净收益/利润总额(%)3.8115.0574.3683.6643.956
营业外收支净额/利润总额(%)-0.952-3.076-1.172-1.370-1.102

偿债能力分析
流动比率 (X)7.2895.6836.4555.8575.929
速动比率 (X)6.3245.0635.6834.9555.043
资产负债率 (%)11.05913.82112.52813.84713.927
带息债务/全部投入资本 (%)2.9214.0961.6490.8500.938
股东权益/带息债务 (%)3,285.8052,309.8425,869.33511,456.12810,330.367
股东权益/负债合计 (%)807.053625.837700.820626.404620.161
利息保障倍数 (X)-82.713-74.711-59.674-46.628-86.642

营运能力分析
应收账款周转天数 (天)90.98679.76966.25162.70757.736
存货周转天数 (天)194.209154.132176.733232.955208.257